BlackRock, Inc. 13D and 13G filings for Reata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA | BlackRock Inc. BLK | 2,501,693 7.900% | 387,643 (+18.34%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA | BlackRock Inc. BLK | 2,114,050 6.700% | 737,966 (+53.63%) | Filing |
| 2020-10-09 09:14 am Sale | 2020-09-30 | 13G | Reata Pharmaceuticals, Inc. RETA | BlackRock Inc. BLK | 1,376,084 4.800% | -867,787 (-38.67%) | Filing |